TD Waterhouse Canada’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.37M | Buy |
14,102
+4,479
| +47% | +$2.02M | 0.05% | 239 |
|
|
2025
Q1 | $4.65M | Buy |
9,623
+783
| +9% | +$378K | 0.04% | 270 |
|
|
2024
Q4 | $3.56M | Buy |
8,840
+6,386
| +260% | +$2.57M | 0.03% | 309 |
|
|
2024
Q3 | $1.15M | Buy |
2,454
+1,489
| +154% | +$699K | 0.01% | 481 |
|
|
2024
Q2 | $455K | Sell |
965
-4,330
| -82% | -$2.04M | ﹤0.01% | 612 |
|
|
2024
Q1 | $2.18M | Buy |
5,295
+1,043
| +25% | +$429K | 0.02% | 380 |
|
|
2023
Q4 | $1.78M | Sell |
4,252
-1,258
| -23% | -$527K | 0.02% | 349 |
|
|
2023
Q3 | $1.99M | Buy |
5,510
+1,202
| +28% | +$435K | 0.02% | 317 |
|
|
2023
Q2 | $1.51M | Buy |
4,308
+3,152
| +273% | +$1.11M | 0.02% | 358 |
|
|
2023
Q1 | $369K | Sell |
1,156
-1,729
| -60% | -$552K | ﹤0.01% | 568 |
|
|
2022
Q4 | $841K | Sell |
2,885
-8,258
| -74% | -$2.41M | 0.01% | 434 |
|
|
2022
Q3 | $4.23M | Sell |
11,143
-1,390
| -11% | -$528K | 0.05% | 206 |
|
|
2022
Q2 | $4.56M | Sell |
12,533
-22
| -0.2% | -$8K | 0.05% | 207 |
|
|
2022
Q1 | $4.11M | Sell |
12,555
-16,737
| -57% | -$5.48M | 0.04% | 237 |
|
|
2021
Q4 | $6.53M | Buy |
+29,292
| New | +$6.53M | 0.06% | 183 |
|